BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 19917249)

  • 1. The homeodomain protein HOXB13 regulates the cellular response to androgens.
    Norris JD; Chang CY; Wittmann BM; Kunder RS; Cui H; Fan D; Joseph JD; McDonnell DP
    Mol Cell; 2009 Nov; 36(3):405-16. PubMed ID: 19917249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HOXB13 induces growth suppression of prostate cancer cells as a repressor of hormone-activated androgen receptor signaling.
    Jung C; Kim RS; Zhang HJ; Lee SJ; Jeng MH
    Cancer Res; 2004 Dec; 64(24):9185-92. PubMed ID: 15604291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HOXB13 promotes androgen independent growth of LNCaP prostate cancer cells by the activation of E2F signaling.
    Kim YR; Oh KJ; Park RY; Xuan NT; Kang TW; Kwon DD; Choi C; Kim MS; Nam KI; Ahn KY; Jung C
    Mol Cancer; 2010 May; 9():124. PubMed ID: 20504375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of androgen receptor-mediated transcription by RPB5 binding protein URI/RMP.
    Mita P; Savas JN; Djouder N; Yates JR; Ha S; Ruoff R; Schafler ED; Nwachukwu JC; Tanese N; Cowan NJ; Zavadil J; Garabedian MJ; Logan SK
    Mol Cell Biol; 2011 Sep; 31(17):3639-52. PubMed ID: 21730289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recruitment of HDAC4 by transcription factor YY1 represses HOXB13 to affect cell growth in AR-negative prostate cancers.
    Ren G; Zhang G; Dong Z; Liu Z; Li L; Feng Y; Su D; Zhang Y; Huang B; Lu J
    Int J Biochem Cell Biol; 2009 May; 41(5):1094-101. PubMed ID: 19013255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Androgen receptor as a regulator of ZEB2 expression and its implications in epithelial-to-mesenchymal transition in prostate cancer.
    Jacob S; Nayak S; Fernandes G; Barai RS; Menon S; Chaudhari UK; Kholkute SD; Sachdeva G
    Endocr Relat Cancer; 2014 Jun; 21(3):473-86. PubMed ID: 24812058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HOXB13 suppresses de novo lipogenesis through HDAC3-mediated epigenetic reprogramming in prostate cancer.
    Lu X; Fong KW; Gritsina G; Wang F; Baca SC; Brea LT; Berchuck JE; Spisak S; Ross J; Morrissey C; Corey E; Chandel NS; Catalona WJ; Yang X; Freedman ML; Zhao JC; Yu J
    Nat Genet; 2022 May; 54(5):670-683. PubMed ID: 35468964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 14-3-3 sigma increases the transcriptional activity of the androgen receptor in the absence of androgens.
    Quayle SN; Sadar MD
    Cancer Lett; 2007 Aug; 254(1):137-45. PubMed ID: 17433535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Homeobox gene, HOXB13, Regulates a Mitotic Protein-Kinase Interaction Network in Metastatic Prostate Cancers.
    Yao J; Chen Y; Nguyen DT; Thompson ZJ; Eroshkin AM; Nerlakanti N; Patel AK; Agarwal N; Teer JK; Dhillon J; Coppola D; Zhang J; Perera R; Kim Y; Mahajan K
    Sci Rep; 2019 Jul; 9(1):9715. PubMed ID: 31273254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HOXC8 inhibits androgen receptor signaling in human prostate cancer cells by inhibiting SRC-3 recruitment to direct androgen target genes.
    Axlund SD; Lambert JR; Nordeen SK
    Mol Cancer Res; 2010 Dec; 8(12):1643-55. PubMed ID: 21047772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two androgen response elements in the androgen receptor coding region are required for cell-specific up-regulation of receptor messenger RNA.
    Dai JL; Burnstein KL
    Mol Endocrinol; 1996 Dec; 10(12):1582-94. PubMed ID: 8961268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cooperative demethylation by JMJD2C and LSD1 promotes androgen receptor-dependent gene expression.
    Wissmann M; Yin N; Müller JM; Greschik H; Fodor BD; Jenuwein T; Vogler C; Schneider R; Günther T; Buettner R; Metzger E; Schüle R
    Nat Cell Biol; 2007 Mar; 9(3):347-53. PubMed ID: 17277772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ATRA inhibits the proliferation of DU145 prostate cancer cells through reducing the methylation level of HOXB13 gene.
    Liu Z; Ren G; Shangguan C; Guo L; Dong Z; Li Y; Zhang W; Zhao L; Hou P; Zhang Y; Wang X; Lu J; Huang B
    PLoS One; 2012; 7(7):e40943. PubMed ID: 22808286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MEIS1 functions as a potential AR negative regulator.
    Cui L; Li M; Feng F; Yang Y; Hang X; Cui J; Gao J
    Exp Cell Res; 2014 Oct; 328(1):58-68. PubMed ID: 25158280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The corepressors silencing mediator of retinoid and thyroid hormone receptor and nuclear receptor corepressor are involved in agonist- and antagonist-regulated transcription by androgen receptor.
    Yoon HG; Wong J
    Mol Endocrinol; 2006 May; 20(5):1048-60. PubMed ID: 16373395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ING3 promotes prostate cancer growth by activating the androgen receptor.
    Nabbi A; McClurg UL; Thalappilly S; Almami A; Mobahat M; Bismar TA; Binda O; Riabowol KT
    BMC Med; 2017 May; 15(1):103. PubMed ID: 28511652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitivity of HOXB13 as a Diagnostic Immunohistochemical Marker of Prostatic Origin in Prostate Cancer Metastases: Comparison to PSA, Prostein, Androgen Receptor, ERG, NKX3.1, PSAP, and PSMA.
    Kristiansen I; Stephan C; Jung K; Dietel M; Rieger A; Tolkach Y; Kristiansen G
    Int J Mol Sci; 2017 May; 18(6):. PubMed ID: 28555048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PLZF regulates Pbx1 transcription and Pbx1-HoxC8 complex leads to androgen-independent prostate cancer proliferation.
    Kikugawa T; Kinugasa Y; Shiraishi K; Nanba D; Nakashiro K; Tanji N; Yokoyama M; Higashiyama S
    Prostate; 2006 Jul; 66(10):1092-9. PubMed ID: 16637071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KAT8 Regulates Androgen Signaling in Prostate Cancer Cells.
    Kim JY; Yu J; Abdulkadir SA; Chakravarti D
    Mol Endocrinol; 2016 Aug; 30(8):925-36. PubMed ID: 27268279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nelfinavir inhibits regulated intramembrane proteolysis of sterol regulatory element binding protein-1 and activating transcription factor 6 in castration-resistant prostate cancer.
    Guan M; Fousek K; Chow WA
    FEBS J; 2012 Jul; 279(13):2399-411. PubMed ID: 22540830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.